Abbott Labs to pay $160M over kickbacks, false diabetes claims
Share!
Business Insurance - Aug 02, 2021
Abbott Laboratories will pay $160 million to resolve claims that two of its units submitted false claims to Medicare by providing kickbacks to diabetes patients, including “free” or “no-cost” glucose monitors, the U.S. Department of Justice said....
Recommended Articles